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Regulatory T (Treg) cells, driven by the Foxp3 tran-
scription factor, are responsible for limiting autoim-
munity and chronic inflammation. We showed that
a well-characterized Foxp3gfp reporter mouse, which
expresses an N-terminal GFP-Foxp3 fusion protein,
is a hypomorph that causes profoundly accelerated
autoimmune diabetes on a NOD background.
Although natural Treg cell development and in vitro
function are not markedly altered in Foxp3gfp NOD
and C57BL/6 mice, Treg cell function in inflammatory
environments was perturbed and TGF-b-induced
Treg cell development was reduced. Foxp3gfp was
unable to interact with the histone acetyltransferase
Tip60, the histone deacetylase HDAC7, and the
Ikaros family zinc finger 4, Eos, which led to reduced
Foxp3 acetylation and enhanced K48-linked polyubi-
quitylation. Collectively this results in an altered tran-
scriptional landscape and reduced Foxp3-mediated
gene repression, notably at the hallmark IL-2
promoter. Loss of controlled Foxp3-driven epige-
netic modification leads to Treg cell insufficiency
that enables autoimmunity in susceptible environ-
ments.
INTRODUCTION
Optimal immune regulation is essential for dampening ongoing
immune responses and preventing damaging autoimmune
pathology. CD4+Foxp3+ regulatory T (Treg) cells are a major
immunosuppressive cell population responsible for controlling
inflammation and autoimmune responses, such as inflammatory
bowel disease (IBD) and type 1 diabetes (T1D) (Coombes et al.,
2005; Vignali et al., 2008). Mutations in the human FOXP3 locus
result in the loss of Treg cells and development of immunodysre-gulation polyendocrinopathy enteropathy X-linked (IPEX), severe
autoimmune and inflammatory syndrome (Campbell and Ziegler,
2007). Likewise, mice that carry the lethal Scurfy mutation or
genetic deletion of Foxp3 also lack Treg cells leading to T cell
dysregulation, widespread autoimmunity, and eventual death
by 3–5 weeks of age. Thus, Foxp3 is an essential transcription
factor that is required for Treg cell development and function.
There are two types of CD4+Foxp3+ Treg cells. Natural Treg
(nTreg) cells develop in the thymus during T cell selection,
whereas induced Treg (iTreg) cells develop after TGF-b cytokine
exposure in the periphery from naive CD4+ T cells. Whereas
nTreg cells are generated in restricted niches in the thymus as
a consequence of high-affinity T cell receptor (TCR) stimulation
(Bautista et al., 2009; Hsieh et al., 2004), iTreg cells can be
generated in response to antigenic stimulation at mucosal sites,
during chronic inflammation, or after induction of transplantation
tolerance (Curotto de Lafaille and Lafaille, 2009). Even though
autoimmune diabetes will eventually develop in NOD mice,
a model for T1D in humans, Treg cells can limit disease progres-
sion as shown by the fact that acute Foxp3+ Treg cell deletion
can rapidly accelerate diabetes onset (Chen et al., 2005; Feuerer
et al., 2009). The relative contribution of nTreg and iTreg cells in
controlling disease progression is currently unknown. Adoptive
transfer of islet-specific iTreg cells was sufficient to restore
euglycemia in diabetic mice (Tarbell et al., 2007). Also, recent
studies suggest that Foxp3+ iTreg cells can develop in the islets
during the natural disease course and can contribute to the
control of diabetes onset and disease progression (Bluestone
and Tang, 2005; Thompson et al., 2011; Wan and Flavell, 2007).
Although considerable insight has been gained into the mech-
anism of Foxp3 function, important questions remain. Foxp3 is
known to induce and repress gene expression either directly or
in concert with a host of interacting proteins in a tightly regulated
manner (Marson et al., 2007; Zheng and Rudensky, 2007). Foxp3
competes with Fos-Jun heterodimers for NFAT transcription
factor binding, which allows for transcription of Treg cell-specific
genes as well as the production of inhibitory cytokines, such as
IL-10 (Bettini and Vignali, 2009; Campbell and Ziegler, 2007). A
large number of genes are repressed by Foxp3 in Treg cells,Immunity 36, 717–730, May 25, 2012 ª2012 Elsevier Inc. 717
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Figure 1. Foxp3gfp NODMiceDevelop Accelerated AutoimmuneDia-
betes
(A) Female Foxp3gfp (n = 29), Foxp3gfp/wt HET (n = 19), and WT (n = 25)
NOD mice in the same colony were monitored weekly for diabetes onset
(***p < 0.001, **p < 0.003; Kalpan-Meier with groups compared with the Log-
rank test).
(B) Insulitis scoring of Foxp3gfp andWTNODmicewas performed at 8weeks of
age.
(C) Cellular infiltrate in the islets, PLN, and spleen of 8-week-old prediabetic
WT, Foxp3gfp, and FoxP3GFP-hCre NOD mice were analyzed by flow cytometry
(n = 6–10 mice per group; *p < 0.05, **p < 0.01, ***p < 0.001). Error bars
represent SEM.
Immunity
Foxp3gfp Causes Treg Cell Insufficiencya process that is dependent on its interaction with transcription
factors like Ikaros family zinc-finger 4, Eos (Hill et al., 2007;
Pan et al., 2009). In addition to modulating the expression of718 Immunity 36, 717–730, May 25, 2012 ª2012 Elsevier Inc.numerous genes, Foxp3 also regulates its own expression
(Tone et al., 2008; Williams and Rudensky, 2007).
Foxp3 also associates with many proteins that epigenetically
modulate transcriptional activity of target gene loci by altering
its DNA methylation, transcription factor associations, and
histone posttranslational modifications. These include the
histone acetyltransferases (HAT) Tip60 and p300 and the histone
deacetylase (HDAC) HDAC7 (Li et al., 2007; Tao et al., 2007).
Thus Foxp3:HDAC and Foxp3:HAT complexes may modulate
target gene expression via histone or Foxp3 acetylation or de-
acetylation. However, the physiological contribution and impact
of these events in shaping Treg cell development and function,
their contribution to nTreg and iTreg cell stability or function,
and how this might impact diabetes progression remain unclear.
This project was initiated by a striking and serendipitous
observation. Foxp3gfp mice (MGI: Foxp3tm2Ayr), a frequently
used Treg cell reporter mouse line, were generated by fusing
GFP to the amino terminus of Foxp3 (Fontenot et al., 2005).
Although Foxp3gfp C57BL/6mice had no apparent diseasemani-
festations or Treg cell abnormalities, Foxp3gfp NOD mice, which
we generated to track and analyze Treg cells in this model of
T1D, developed dramatically accelerated autoimmune diabetes
with 100% penetrance. Subsequent analysis of Foxp3gfp NOD
and C57BL/6 mice identified this knockin as a hypomorphic
allele, which we used to gain insight into the mechanism and
function of Foxp3. We showed that Foxp3gfp failed to associate
with Tip60, HDAC7, and Eos, which led to altered Foxp3-depen-
dent transcription and epigenetic modification. This led to nTreg
cell insufficiency and impaired iTreg cell development.
RESULTS
Foxp3gfp NOD Mice Develop Accelerated Autoimmune
Diabetes
Foxp3gfp C57BL/6 mice were bred onto the NOD/LtJ back-
ground. As expected, 80% of the littermate NOD control female
mice became diabetic by30 weeks of age (Figure 1A). Surpris-
ingly, the Foxp3gfp NOD mice exhibited substantially increased
incidence of diabetes with 100% penetrance by 12 weeks of
age, when only 10% of wild-type (WT) female NOD mice had
become diabetic (Figure 1A). The Foxp3 gene is located on the
X chromosome, so Foxp3gfp/wt NOD heterozygous (HET) female
mice have half their Treg cells expressing WT Foxp3 and half
expressing the Foxp3gfp fusion protein as a result of random
X-inactivation. The Foxp3gfp/wt NOD HET mice developed an
intermediate incidence of diabetes and onset kinetics with
47% diabetic at 12 weeks (Figure 1A). These data suggest that
the 50% WT Treg cells present in these mice were unable to
prevent accelerated autoimmune diabetes.
We next analyzed the islet infiltrate of prediabetic mice. At
8 weeks of age, Foxp3gfp NOD mice exhibited substantially
increased peri-insulitis and invasive insulitis compared with
NOD WT controls (Figure 1B). This correlated with an increase
in the number of CD4+ T cells within the islets of Foxp3gfp NOD
mice compared to WT NOD mice and Foxp3GFP-hCre NOD BAC
transgenic mice (MGI: Tg(Foxp3-EGFP/cre)1aJbs) (Zhou et al.,
2008, 2009), included as an additional control that had a compa-
rable diabetes incidence to WT NOD mice (Figure 1C). Interest-
ingly, there was a significant decrease in the percentage of
Immunity
Foxp3gfp Causes Treg Cell InsufficiencyFoxp3+ Treg cells within the islets and peripheral secondary
lymphoid organs of Foxp3gfp NOD mice compared to WT NOD
or Foxp3GFP-hCre NOD control mice (Figure 1C).
To better assess the cell-intrinsic defect of Foxp3gfp, we
further analyzed Foxp3gfp/wt NOD HET female mice to compare
the relative ratio and expression of the Foxp3 protein. Foxp3
expression (MFI) was significantly increased in Foxp3gfp Treg
cells in all lymphoid and nonlymphoid organs including the islets
when compared withWT Foxp3+ Treg cells (Figure S1A available
online). The increased expression of Foxp3 did not appear to be
a consequence of higher Foxp3 transcription as determined by
real-time PCR analysis of Treg cells isolated from Foxp3gfp
NODHETmice (Figure S1B). Whereas a50:50 ratio of Foxp3gfp
versus WT Treg cells was found in the thymus, spleen, inguinal
lymph nodes (LNs), and lung, a modest increase in the
percentage of Foxp3gfp Treg cells was observed in the liver.
Also, thymic Treg cell development appeared largely intact on
the NOD background. Interestingly, the mesenteric lymph nodes
(MLNs), pancreatic lymph nodes (PLNs), and islets displayed
a reduced Foxp3gfp:WT Treg cell ratio in Foxp3gfp NOD HET
mice, suggesting that this may occur at or near draining sites
of inflammation (Figure S1A). To determine whether this was
due to reduced proliferation, we assessed expression of the
cell cycle protein Ki67 in Foxp3gfp and WT Treg cells. There
was a slight but significant decrease in the percentage of Ki67+
Foxp3gfp Treg cells in the islets and MLNs but not in the PLNs
(Figure S1A). Thus, although the reduced number of Foxp3gfp
Treg cells observed may be impacted by reduced proliferative
potential, we cannot rule out the possibility that there may also
be reduced survival or migration to these inflammatory sites.
Nevertheless, the reduction observed is presumably a cell-
intrinsic defect in Foxp3gfp Treg cells because this was not
observed with the WT Treg cells in the same Foxp3gfp NOD
HET microenvironment.
We then performed a mixed reconstitution assay in NOD.scid
mice to determine whether the accelerated autoimmune dia-
betes in the Foxp3gfp mice was due to defects in nTreg cells,
iTreg cells, or both. Mice received the same number of CD4-
depleted splenocytes plus different combination of WT or
Foxp3gfp conventional T (Tconv) cells and WT or Foxp3gfp Treg
cells at a 10:1 ratio, and recipients were monitored for disease
incidence over 30 weeks. This experimental set up allowed us
to assess the ability of the two nTreg cell populations to limit
disease and to determine whether any iTreg cells that emerge
from the two Tconv cell populations contribute to immune regu-
lation. Interestingly, the two Foxp3gfp Treg cell recipient groups
developed accelerated diabetes onset compared with their
wild-type counterparts (4 weeks versus 12 weeks, respec-
tively), although it was not fully penetrant and the incidence at
30 weeks was the same for all four groups (Figure S1C). These
data suggest that the Foxp3gfp Treg cells may not be as effective
as WT Treg cells at delaying diabetes onset and that iTreg cells
(generated in vivo from the Tconv cells) are either not generated
or have no impact on diabetes development. The two Foxp3gfp,
but not the WT, Treg cell recipient groups also developed colitis-
like symptoms with severe diarrhea and rectal prolapse, sug-
gesting that the former are unable to prevent intestinal inflamma-
tion in this setting (Figure S1D). Colitis onset and incidence were
exacerbated in the group that also received Tconv cells fromFoxp3gfp mice, which may have been due to limited or ineffective
iTreg cell induction or function. Although a detailed analysis of
the differential impact and contribution of Foxp3gfp nTreg cells
and iTreg cells would require more extensive analysis, taken
together there appears to be substantial Foxp3gfp Treg cell insuf-
ficiency, particularly in highly inflammatory and stressed sites
in vivo (Figures 1 and S1E).
The accelerated diabetes incidence observed coupled with
the reduced number of Treg cells detected in the islets and their
diminished capacity to limit diabetes progression suggests that
the Foxp3gfp knockin mutant may function as a hypomorph
that is particularly penetrant on an autoimmune background,
such as NOD, which may lead to Treg cell insufficiency. This
raised two questions. (1) Are there additional defects in Treg
cell development, homeostasis, and/or function caused by
expression of the Foxp3gfp hypomorph? (2)What is themolecular
basis for the defects observed?
Foxp3gfp nTreg Cell Insufficiency In Vivo
Although Foxp3gfp C57BL/6 mice do not manifest any noticeable
autoimmune or inflammatory lesions, the knockin mutation is the
same and thus may still impart some defect or insufficiency.
Therefore we included WT and Foxp3gfp mice (C57BL/6
background), as well as Foxp3DTR-GFP C57BL/6 mice (MGI:
Foxp3tm3Ayr), a control GFP knockin that does not exhibit any
defects (Kim et al., 2007), in subsequent analysis. Although there
was a reduced ratio of Foxp3gfp versus WT Treg cells in Foxp3gfp
C57BL/6 HET mice, this was comparable in the thymus and
secondary lymphoid sites (LNs, spleen), suggesting subtle
developmental defect (Figure S2A). It is possible that the Treg
cell insufficiency seen in NOD mice, manifest as reduced Treg
cell numbers and an inability to limit diabetes onset, is a conse-
quence of the ‘‘challenges’’ placed on Treg cells in an autoim-
mune or inflammatory environment. To determine whether this
ratio is further perturbed in inflammatory sites, Foxp3gfp
C57BL/6 HET mice were injected with B16 melanoma cells
and analyzed 14 days later. Consistent with observations in the
islets of Foxp3gfp NOD mice, there was a substantially reduced
ratio of Foxp3gfp Treg cells in the inflammatory tumor microenvi-
ronment in contrast to the spleen (Figure S2B).
Foxp3gfp Treg cells on either a NOD or C57BL/6 background
were functionally equivalent in an in vitro suppression assay
(Figures S2C and S2D). Likewise, Foxp3gfp and WT C57BL/6
Treg cells were equally capable of suppressing the homeostatic
proliferation of Tconv cells in lymphopenic Rag1/ mice (Fig-
ure 2A). To test the fitness and function of Foxp3gfp Treg cells
in a more stringent model, their capacity to prevent systemic
autoimmunity was assessed in Foxp3/ mice, which die at
3–5 weeks of age without adoptive transfer of exogenous
Treg cells. CD4+CD45RBloCD25+ Treg cells from WT and
Foxp3gfp C57BL/6 mice were injected intraperitoneally into
2- to 3-day-old Foxp3/ mice. At day 35, mice were assessed
by histological score and the number of CD4+ T cells in the
spleen and LNs. Interestingly, Foxp3gfp Treg cell recipients
exhibited a significant increase in cumulative histological score
(liver, skin, and lung) and the number of CD4+ T cells in the spleen
and LNs of WT and Foxp3gfp Treg cell recipients (Figures 2B
and 2C). Although this caused a significant reduction in the
percentage of Foxp3gfp Treg cells compared with WT Treg cells,Immunity 36, 717–730, May 25, 2012 ª2012 Elsevier Inc. 719
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Figure 2. Foxp3gfp nTreg Cell Insufficiency In Vivo
(A) Thy1.1+ Tconv (2 3 106 CD4+CD45RB+CD25 from C57BL/6 mice; >99% purity postsort) cells were injected into Rag1/ mice or mixed with Thy1.2+ Treg
cells (0.53 106) from either WT or Foxp3gfp C57BL/6 mice (CD4+CD45RBloCD25+; >95% purity postsort, confirmed by Foxp3 intracellular stain). The number of
CD4+Thy1.1+ splenic T cells was determined 7 days later. 11–20 mice per group from 4 separate experiments are shown. Statistical analysis was one-way
ANOVA analysis of variance (**p < 0.01 and ***p < 0.001).
(B and C) Foxp3/mice (2–3 days old) were adoptively transferred with 106 sorted Treg cells (CD4+CD45RBloCD25+) from either WT or Foxp3gfp C57BL/6 mice
(>95% purity by Foxp3 intracellular stain). After 35 days, mice were sacrificed and CD4+ T cell numbers and Foxp3+ percentages in the spleens and peripheral
LNs were quantified. Three separate experiments with 5–9 mice per group are shown (*p < 0.05, ***p < 0.001). Error bars represent SEM.
(D) Foxp3/mice treated as in (C) were evaluated over 18 weeks for clinical signs of autoimmunity. When mice reached a clinical score of five (out of six), they
were euthanized. n = 10 mice/group (**p < 0.01, ***p < 0.001; Kalpan-Meier with groups compared with the Log-rank test).
Immunity
Foxp3gfp Causes Treg Cell Insufficiencythe number of Foxp3gfp and WT Treg cells was the same (Fig-
ure 2C). Collectively, these data suggest that there may not be
a reduction in the systemic ‘‘fitness’’ of Foxp3gfp Treg cells,
although this may be compromised at sites of inflammation.
Regardless, Foxp3gfp Treg cells are unable to limit the immune
pathology observed and there appears to be a deficiency in
the capacity of Foxp3gfp Treg cells to suppress the T helper 1
(Th1) cell-driven pathology in Foxp3/ mice.
Differences in histological score and CD4+ T cell numbers
were far greater at 35 days versus 23 days posttransfer, sug-
gesting a progressive failure of Foxp3gfp Treg cells over time
(Figures 2B and 2C and data not shown). Therefore, we asked
whether there were differences in the length of time Foxp3gfp or
WT Treg cells could control the onset of autoimmunity that
develops in Foxp3/ mice. Strikingly, Foxp3/ mice reconsti-
tuted with Foxp3gfp Treg cells developed autoimmune symp-
toms significantly faster than WT Treg cell recipients (Fig-
ure 2D). Taken together, these data suggest that although
Foxp3gfp Treg cells appear to retain normal in vitro suppressive
activity, they exhibit substantial functional insufficiency in vivo,
particularly in highly stressed environments that may impact720 Immunity 36, 717–730, May 25, 2012 ª2012 Elsevier Inc.their capacity to limit chronic autoimmune or inflammatory
diseases.
Impaired Development of Foxp3gfp iTreg Cells
TGF-b-induced Treg (iTreg) cells are generated at inflammatory
sites and can contribute to immune homeostasis (Curotto de
Lafaille et al., 2008; Geuking et al., 2011; Thompson et al.,
2011). We sought to determine whether there was a defect in
iTreg cell development from Foxp3gfp Tconv cells. Consistently,
diminished expression of Foxp3 was observed with CD4+
CD45RBhiCD25GFP Foxp3gfp NOD and C57BL/6 Tconv cells
stimulated with anti-CD3- and anti-CD28-coated beads, TGF-
b, and IL-2 compared with WT and Foxp3GFP-hCre/Foxp3DTR-GFP
controls (Figures S3A and S3B). We next utilized Foxp3gfp/wt
female HETNODandC57BL/6mice to determinewhether Tconv
cells that could express the Foxp3gfp fusion protein had any
competitive disadvantage over cells that could express WT
Foxp3. There was a 50% reduction in the efficiency of Foxp3+
iTreg cell conversion with cells expressing Foxp3gfp compared
withWT Foxp3 (Figures 3A, 3B, and S3C). The lack of conversion
observed did not appear to be due to an increase in cell death by
Figure 3. Impaired Foxp3gfp iTreg Cell Conversion In Vitro
(A) CD4+CD45RBhiCD25 Tconv cells were purified from Foxp3gfp/wt NOD HET mice and stimulated with anti-CD3/CD28-coated beads, 5 ng/ml TGF-b, and
100 U/ml IL-2. After 5 days, cells were stained with anti-Foxp3. Cells were gated on GFP+Foxp3+ and GFPFoxp3+. A representative flow plot and an average of
five experiments are shown (**p < 0.01 by 2-way analysis paired t test).
(B) CD4+CD45RBhiCD25 Tconv cells were sorted from Foxp3gfp and Foxp3DTR-GFP C57BL/6 HETmice, stimulated, and analyzed as in (A). A representative of six
separate experiments is shown (***p < 0.001 by 2-way analysis paired t test).
Immunity
Foxp3gfp Causes Treg Cell Insufficiencyapoptosis or alteredproliferative capacity (FigureS3D).However,
thecells that did convert to iTregcells appear to havecomparable
in vitro suppressive capacity (Figures S4A and S4B). Taken
together, these data indicated a substantial deficiency in the
ability of Foxp3gfp Tconv cells to convert into Foxp3+ iTreg cells.
We then assessed the capacity of Foxp3gfp Tconv cells
to convert into Foxp3+ iTreg cells in two in vivo models. First,
CD4+CD45RBhiCD25 Tconv cells from WT and Foxp3gfp NOD
mice were injected intravenously into NOD.scid mice and
the number and percentage of Foxp3+ iTreg cells in the spleen
and MLN were determined 21 days later. Substantially reduced
conversion of Foxp3gpf Tconv (Foxp3) into Foxp3+ iTreg
cells was observed in both lymphoid sites when compared
with WT controls (Figures 4A and 4B). Despite the lack of
autoimmune or inflammatory disease in Foxp3gfp C57BL/6
mice, an essentially identical defect in iTreg cell generation
after transfer of CD4+CD45RBhiCD25 Tconv cells from Foxp3gfp
C57BL/6 mice into Rag1/ mice was observed. Furthermore,
the ratio of converted Foxp3+ cells was skewed toward cells ex-
pressing WT Foxp3 after transfer of Tconv cells from Foxp3gfp/wt
C57BL/6 HET mice injected into Rag1/mice (Figure 4C).
Second, CD45.1+ congenic mice were injected intravenously
with a 50:50 ratio of Thy1.1+CD45.2+CD4+CD45RBhiCD25Tconv cells from WT OT-II TCR transgenic mice and from
Foxp3gfp OT-II mice and given OVA antigen in the drinking water.
After 6 days, the percentage of Foxp3+ iTreg cells in the spleen
and peripheral LNs was determined. Consistent with the obser-
vations above, the ratio of Foxp3+ iTreg cells was highly skewed
toward WT Foxp3+ versus Foxp3gfp iTreg cells, which was
particularly evident in the Peyer’s patches (PP) and the MLN
(Figure 4D). Given that the proliferative capacity of WT and
Foxp3gfp iTreg cells was comparable (Figure S4C), the lack of
Foxp3gfp iTreg cell development is probably due to diminished
rate of stable Foxp3gfp expression.
Taken together, these data suggest a defect in the capacity of
Foxp3gfp Tconv cell to induce Foxp3 expression and convert into
iTreg cells. Expression of the Foxp3gfp hypomorph limits iTreg
cell development and causes nTreg cell insufficiency, resulting
in a substantial impact on their capacity to control autoimmune
and inflammatory disease.
Foxp3gfp Exhibits Selective Impaired Molecular
Interactions
Certain epigenetic modifications of the Foxp3 locus and molec-
ular associations between Foxp3 and a variety of transcription
factors and modifying proteins have been collectively shown toImmunity 36, 717–730, May 25, 2012 ª2012 Elsevier Inc. 721
Figure 4. Impaired Development of Foxp3gfp iTreg Cells In Vivo
CD4+CD45RBhiCD25 Tconv cells were sorted (>98% purity) from Foxp3gfp and WT C57BL/6 or NOD mice and 2 3 106 cells injected i.v. into Rag1/ or
NOD.SCID mice, respectively. Mice were sacrificed 21 days postinjection; spleens and LNs were harvested and stained for CD4, CD25, and intracellular Foxp3.
(A) Representative flow plots.
(B) Percentage and total number of CD4+Foxp3+ cells in spleens and MLNs (n = 9 mice per group, ***p < 0.001, *p < 0.03).
(C) CD4+CD45RBhiCD25 Tconv cells (C57BL/6 Foxp3gfp/wt HET mice, >99% purity; 2 3 106) were injected i.v. into Rag1/ mice and analyzed as in (A)
(n = 9 mice; *p < 0.05 by 2-way analysis paired t test).
(D) CD45.1+ C57BL/6 mice were injected i.v. with a 50:50 mixture of OT-II CD4+CD45RBhiCD25 Tconv cells (>99.7% Foxp3) from either Thy1.1+CD45.2+ WT
OT-II mice or Thy1.2+CD45.2+ Foxp3gfp OT-II mice and placed on drinking water with OVA antigen. After 6 days, the percentage of Foxp3+ iTreg cells in PP, MLN,
spleen, and peripheral LN was determined (n = 15; **p < 0.005, *p < 0.05 by 2-way analysis paired t test).
Immunity
Foxp3gfp Causes Treg Cell Insufficiency
722 Immunity 36, 717–730, May 25, 2012 ª2012 Elsevier Inc.
Immunity
Foxp3gfp Causes Treg Cell Insufficiencymodulate Treg cell stability, homeostasis, migration, and func-
tion. Therefore, we assessed whether the Foxp3 N-terminal
fusion of GFP had altered any specific associations or epigenetic
modifications that might underlie the phenotypic defects
observed. The methylation status of the CpG-rich Treg cell-
specific demethylated region (TSDR) of the Foxp3 locus has
been shown to correlate with Treg cell stability (Baron et al.,
2007; Floess et al., 2007; Nagar et al., 2008). However, no differ-
ences in the methylation status of the Foxp3 TSDR were
observed in Foxp3gfp nTreg or iTreg cells compared with their
respective controls (Figure S5A).
We next examined the stability of protein:protein interactions
known to occur between Foxp3 and other transcription factors
or epigenetic modifiers that collectively shape the Treg cell tran-
scriptional landscape. There was a complete loss of Tip60 HAT
association and partial reduction of p300 HAT association with
Foxp3gfp but not WT Foxp3 (Figures 5A and 5B). There was
also a partial reduction in Foxp3:Tip60 association in Foxp3gfp
iTreg cells compared with their Foxp3GFP-hCre counterparts (Fig-
ure S5B). There was also a substantially reduced association
between HDAC7 and Foxp3gfp but not WT Foxp3 (Figure 5C).
Taken together, these data suggested that epigenetic modifica-
tions driven by the association between Foxp3 and Tip60 and/or
HDAC7 might be deficient.
Gene repression by Foxp3 ismediated by Eos, an Ikaros family
zinc-finger transcription factor (Pan et al., 2009). Foxp3gfp ex-
hibited substantially reduced association with Eos compared
with WT Foxp3 in nTreg and iTreg cells (Figures 5D and S5C).
Given that Eos, Tip60, and HDAC7 are known to associate
with the N-terminal region of Foxp3 (Xiao et al., 2010), we exam-
ined association with NFAT and AML-1 (Runx-1), two known
Foxp3 C-terminal associated proteins. No differences were
observed in the association of NFAT or AML-1 with Foxp3gfp
compared with WT Foxp3 (Figure 5E and data not shown).
Furthermore, luciferase reporter assays demonstrated a compa-
rable ability of Foxp3gfp and WT Foxp3 to repress NFAT and
RORa promoter activity (Figure S5D). Similar results were
observed after cotransfection of HEK293T cells with plasmids
encoding Foxp3gfp or WT Foxp3 and NFAT, Eos, or Tip60,
demonstrating that the differential associations observed in
Treg cells were inherent properties of the Foxp3gfp fusion protein
rather than an indirect consequence of Treg cell dysregulation
(Figures S5E–S5G). These data suggest that Foxp3gfp
possesses a selective defect that is limited to interactions
utilizing the Foxp3 N terminus.
Tip60 has been shown to be responsible for the acetylation
of Foxp3 while HDAC7 is involved in the deacetylation and
inactivation of Foxp3 (Xiao et al., 2010). The consequence of
losing both associations and how this might affect Foxp3 acet-
ylation is unclear. Interestingly, total acetyllysine was reduced
on Foxp3gfp compared with WT Foxp3 in nTreg and iTreg cells
(Figures 5F and S5H), suggesting that the loss of Tip60:Foxp3
interaction may result in reduced Foxp3gfp stability and/or
function (Li et al., 2007). There was a marked increase in total
ubiquitylation and K48-linked polyubiquitylation of Foxp3gfp
compared with WT Foxp3 (Figure 5G), suggesting that there
may be increased Foxp3gfp proteasomal degradation and/or
altered transcriptional activity. Furthermore, Foxp3gfp NOD
nTreg and iTreg cells showed a small but significant reductionin Foxp3 protein half-life compared with WT Foxp3 NOD Treg
cells (Figure S6A). These data raise the possibility that this
subtle increase in Foxp3gfp instability could accumulate over
time and/or have a greater impact at sites of inflammation
in vivo.
In order to provide further insight into the global transcriptional
consequences of these otherwise selective defects in Foxp3gfp
protein associations and epigenetic modifications, we isolated
mRNA from highly purified CD4+CD3+GFP+ NOD Foxp3gfp and
Foxp3GFP-hCre splenic Treg cells and GFP Tconv cell controls
from 6-week-old prediabetic mice, and we performed Affymetrix
GeneChip microarray analysis with four independent replicates.
Principal component analysis (PCA) demonstrated that the
Foxp3gfp and Foxp3GFP-hCre GFP Tconv cell replicate data
sets were similar as they clustered in close proximity while the
Foxp3GFP-hCre GFP+ Treg cell replicates were tightly clustered
but distinct from the Tconv cell data sets (Figure 6A). Whereas
the Foxp3gfp Treg cell replicates were in close proximity to the
Foxp3GFP-hCre Treg cell, they were dispersed relative to each
other, suggesting some degree of variability between individual
mice within this population. Global analysis of the differentially
expressed genes in Foxp3gfp and Foxp3GFP-hCre Treg cells
compared with their Tconv cell counterparts revealed that they
possessed a predominantly intact Treg cell signature with
many of the genes associated with previously described Treg
cell signatures differentially expressed in both Treg cell popula-
tions (Figures 6B, 6C, and S6B). Nevertheless, differences
were evident between the most differentially expressed genes
among the two Treg cell populations (Figure S6D and S6E).
This is highlighted by several known Treg cell genes being signif-
icantly upregulated in Foxp3gfp Treg cells (Figure 6D). Around
half the most differentially expressed genes between Foxp3gfp
and Foxp3GFP-hCre Treg cells were not Treg cell signature genes
(Figure 6D). For instance, several genes that are expressed in
activated, migratory cells (Ccr2, Ntn1, Itgae, Lamc1, Anxa2,
S100a6) and upregulated (Ikzf3, Bcl2l15, Lgals1, Egln3, Matk)
or downregulated (Arhgap5) in active but dying cells are
differentially expressed in Foxp3gfp Treg cells compared with
their Foxp3GFP-hCre Treg cell controls, which collectively may
cause deregulated migration and/or altered functional suffi-
ciency in inflammatory environments. Taken together, this
analysis indicates a perturbation in the expression of some but
not all genes that may in turn lead to the Treg cell insufficiency
observed.
Given the altered transcriptional landscape observed, we
questioned whether Foxp3gfp Treg cells exhibited an altered
phenotype that could impact their capacity to suppress the
predominantly Th1 cell-driven disease observed in NOD and
Foxp3/ mice. Expression of the inflammatory cytokines
IFN-g and IL-17 and the transcription factor T-bet, which is
required for selective repression of Th1 cell-driven disease
(Koch et al., 2009), was not altered in Foxp3gfp NOD Treg cells
(Figures S7A and S7B and data not shown). However, the
percentage of Treg cells expressing CXCR3, a T-bet down-
stream target, was reduced in Foxp3gfp NOD mice (Figure S7C).
Consistent with the CD103 (Itgae) upregulation observed in the
Affymetrix analysis, an increased percentage of the CD103+
Treg cell subset was detected in Foxp3gfp versus WT mice (Fig-
ure 6E). Although one might predict that upregulation of twoImmunity 36, 717–730, May 25, 2012 ª2012 Elsevier Inc. 723
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Figure 5. Foxp3gfp Exhibits Selective Impaired Molecular Interactions
CD4+CD45RBloCD25+ WT and Foxp3gfp NOD nTreg cells (sorted to >93% purity) were analyzed by IP/immunoblot with the Abs indicated: anti-Tip60 (A), anti-
p300 (B), anti-HDAC7 (C), anti-Eos (D), anti-NFAT (E), anti-acetyllysine (F), and with either anti-ubiquitin or anti-K48-ubiquitin (G). In (G), IP was also performed
with anti-ubiquitin and then immunoblot with Foxp3. Representative blots of at least three separate experiments are shown.
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Foxp3gfp Causes Treg Cell Insufficiencygenes that contribute to cell migration might increase migration
into inflammatory sites, it is possible that this in fact leads to an
altered migratory pattern. Indeed, there appeared to be a
selective reduction of Treg cells at inflammatory sites in Foxp3gfp
NOD mice and B16 tumor-bearing Foxp3gfp C57BL/6 mice but
an increase in Foxp3gfp Treg cells in the liver (Figures 1C, S1A,
and S2B).724 Immunity 36, 717–730, May 25, 2012 ª2012 Elsevier Inc.A hallmark gene known to be potently repressed by Foxp3 is
IL-2 (Chen et al., 2006; Crispı´n and Tsokos, 2009). Therefore,
IL-2 promoter activity and histone acetylation status can
be used as a surrogate for the general functionality of Foxp3
in Treg cells. Foxp3gfp-expressing Jurkat cells exhibited a
significant increase in IL-2 promoter activity compared to cells
expressing WT Foxp3 (Figure 7A). Furthermore, there was
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Figure 6. Altered Transcriptional Landscape in Foxp3gfp Treg Cells
Foxp3GFP-hCre or Foxp3gfp NOD Treg and Tconv cells purified by FACS (>99% purity), mRNA isolated, and subjected to Affymetrix analysis (four independent
samples per group).
(A) PCA analysis.
(B and C) Volcano plot comparing FoxP3GFP-hCre (B) or Foxp3gfp (C) Treg cells with their respective Tconv cell controls. Highest modulated genes are marked.
(D) Most differentially expressed genes in Foxp3gfp Treg cells compared to wild-type Treg and Tconv cell controls are depicted in a heat map. Treg cell signature
genes are in red (as defined in Figure S6 and Pillai et al., 2011).
(E) FoxP3GFP-hCre/wt or Foxp3gfp/wt HET Treg cells were stained for Itgae (CD103). Data are representative of 5–6mice (**p < 0.01 by two-way analysis paired t test).
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Figure 7. Enhanced IL-2 Promoter Activity and IL-2 Production by Foxp3gfp Treg Cells
(A) Jurkat T cells were transfected with an IL-2-luciferase reporter plasmid along with indicated Foxp3-encoded plasmids. Empty vector pMIY was used to
maintain equal DNA content for all transfections. Cells were either treated with PMA plus ionomycin or left untreated 12 hr posttransfection, prior to analysis
of luciferase activity, which was normalized to the Renilla luciferase activity. Data shown are representative of at least three independent experiments (mean
and SD of triplicate transfections are shown; *p < 0.005 by t test).
(B) ChIP assay was performed with anti-Foxp3 Ab or IgG control followed by PCR by primers flanking the Foxp3-binding region of the IL-2 promoter. Shown are
the mean (±SEM) of at least three independent experiments (**p < 0.001 by t test).
(C) Histone acetylation at the IL-2 promoter was determined by ChIP in the cell subsets indicated. Shown are the mean (±SEM) of at least three independent
experiments (*p < 0.005 by t test). Naive is defined as rested, while Tconv cell is defined as previously activated by anti-CD3/CD28.
(D) CD4+CD45RBloCD25+ Treg cells from WT, Foxp3gfp, and FoxP3GFP-hCre NOD mice were sorted (>95% purity), stimulated (0.5 3 105) with plate-bound anti-
CD3 and soluble anti-CD28 for 72 hr, and IL-2 concentration in supernatants determined by ELISA. Shown are the mean (±SEM) of at least three independent
experiments (*p < 0.05 by 2-way paired t test).
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Foxp3gfp Causes Treg Cell Insufficiencysubstantially diminished Foxp3 binding to the IL-2 promoter in
Foxp3gfp nTreg and iTreg cells compared with WT controls (Fig-
ure 7B and data not shown). Consistent with the reduced
Foxp3gfp:HDAC7 association observed (Figure 5C), histone H3
and H4 lysine acetylation (H3Ac and H4Ac) at the IL-2 promoter
was substantially increased in Foxp3gfp nTreg and iTreg cells
compared with controls, suggesting incomplete repression of
the IL-2 promoter (Figures 7C and S7D). There was a small but
significant increase in the percentage of IL-2+ Foxp3gfp Treg cells
comparedwithWT Treg cells, whichwas approximately a third of
the IL-2+ Tconv cells generated under the same stimulation
conditions (7.1% versus 18.3%; Figure S7E). Furthermore, there
was a significant increase in the IL-2 MFI of Foxp3gfp versus WT
Treg cells. This ultimately led to significant amounts of IL-2
produced by Foxp3gfp Treg cells in contrast with WT Treg cells
(Figure 7D). Taken together, these data show that Foxp3gfp fails
to productively engage with key mediators of its transcription
program, specifically HDAC7, Tip60, and Eos. This leads to726 Immunity 36, 717–730, May 25, 2012 ª2012 Elsevier Inc.a partial loss of gene repression, altered Foxp3 stability, and
limited histone deacetylation at target promoters, such as IL-2,
suggesting that this loss of Foxp3-driven epigenetic modification
may lead to the Treg cell insufficiency and enhanced diabetes
observed in Foxp3gfp NOD mice.
DISCUSSION
Foxp3 acts as a master transcription factor that is essential for
Treg cell development and function, inducing and repressing
a wide variety of genes that collectively constitute the Treg cell
signature (Hill et al., 2007; Marson et al., 2007; Wan and Flavell,
2007; Zheng et al., 2007). These activities are mediated by
its interaction with many transcription factors, such as Eos,
AML1 (Runx-1), NFAT, and RORa, or epigenetic regulators,
such as Tip60 and HDAC7 (Campbell and Ziegler, 2007; Wang
et al., 2009; Xiao et al., 2010). For instance, Foxp3 association
with Eos and HDAC7 mediates the gene repression profile
Immunity
Foxp3gfp Causes Treg Cell Insufficiencycomponent of the Treg cell signature (Li et al., 2007; Pan et al.,
2009), whereas Foxp3 association with Tip60 is thought to
enhance Foxp3 stability (Tao et al., 2007). Although many of
these interactions have been documented and linked to specific
functions, their global physiological contribution to Treg cell
development, homeostasis, and function is unclear. In general,
these proteins interact with many different partners and thus
perform numerous diverse functions. Consequently, targeted
deletion or inhibition of these proteins can produce results that
are difficult to interpret.
Our serendipitous observation that Foxp3gfp was a previously
unrealized hypomorph provided a unique opportunity to probe
the physiological importance of these interactions on Treg cell
development, homeostasis, and function. Indeed, Foxp3gfp
expression on the autoimmune-prone NOD background led to
dramatically accelerated diabetes that was reminiscent of the
exacerbated disease observed after acute Treg cell depletion
(Chen et al., 2005; Feuerer et al., 2009). The molecular defects
described in this study are selective and restricted to associa-
tions with the N terminus of Foxp3, probably because of steric
hindrance caused by the attachment of GFP without a flexible
linker. Thus, interactions with Eos, Tip60, and HDAC7 (this
paper) or Hif1a (Darce et al., 2012) are substantially reduced
or lost, whereas more distal interactions with NFAT, AML1/
Runx-1, and RORa are maintained or even enhanced in the
case of Irf4 (Darce et al., 2012). This presented a unique oppor-
tunity to determine the selective physiological impact of these
altered interactions on Treg cell development and function.
A significantly reduced number of Treg cells was observed in
the islets of Foxp3gfp NOD mice, although the severity of the
disease suggested that factors other than reduced number
also contributed to the precipitous disease onset. Although there
are subtle defects in thymic nTreg cell generation on the
C57BL/6 background (Fontenot et al., 2005), our data clearly
show that Foxp3gfp expression results in nTreg cell insufficiency
in competitive and/or inflammatory environments and limits
iTreg cell generation. Indeed, a substantially reduced number
of Foxp3gfp versus WT Treg cells was observed in B16 tumors.
The contribution, if any, of iTreg cells in limiting the rate of auto-
immune diabetes in NODmice has not been fully determined, so
it is possible that iTreg cells may play a role, as indicated by the
fact that their reduced production may underlie the accelerated
rate of disease onset observed. However, our transfer experi-
ments suggest that there may not be a significant role for iTreg
cells in limiting autoimmune diabetes, although they appeared
to limit colitis.
A curious, and at first glance counterintuitive, observation was
the increased Foxp3 levels in Foxp3gfp NOD Treg cells. Treg cell
activation is known to induce the upregulation of Foxp3, so it is
possible that the enhanced inflammatory environment in the
islets of Foxp3gfp NOD mice causes increased Treg cell activa-
tion, which may in turn induce the increased Foxp3 expression
observed. Although steady-state analysis did not suggest that
there is substantial Foxp3gfp instability, the data were significant
and in an inflammatory environment, Foxp3gfp instability could
be more pronounced. Thus, the increased Foxp3 expression
observed may also be a physiological response to Foxp3 insta-
bility and an attempt to compensate for the defects inherent in
Foxp3gfp Treg cells, which may in turn be induced by the accel-erated disease progression. We have shown that Foxp3gfp is
unable to effectively associate with Tip60 and HDAC7, enzymes
that control acetylation. Given that we see reduced acetylation,
it is possible that the loss of Tip60 causes Foxp3gfp instability
and/or functional insufficiency, because loss of Foxp3:Tip60
association has also been shown to lead to increased Foxp3
expression in 293T cells after Tip60 knockdown (Li et al., 2007;
Tao et al., 2007). This would also be consistent with the
increased K48-linked polyubiquitylation of Foxp3gfp observed,
which typically leads to proteasomal degradation. Interestingly,
it has been suggested that K48-linked polyubiquitylation can
also lead to transcriptional repression without protein degrada-
tion, a possibility that warrants further investigation (Flick et al.,
2004, 2006; Ouni et al., 2011). However, HDAC7 has also been
suggested to deacetylate the ε-acetyllysine residues found on
Foxp3, suggesting a level of complexity that has yet to be fully
understood (Johnstone, 2002; Saouaf et al., 2009). Neverthe-
less, this reduced Foxp3 stabilization may underlie the reduced
iTreg cell conversion and nTreg cell insufficiency observed.
Foxp3 associates with both HDAC7 and Tip60, which are
collectively required for transcriptional repression (Li et al.,
2007; Xiao et al., 2003). Likewise, Foxp3 association with Eos
has been shown to be required for the gene repression compo-
nent of the Treg cell signature (Li et al., 2007; Pan et al., 2009).
Our observation that Foxp3gfp fails to efficiently associate with
Eos, Tip60, and HDAC7, whereas other known associations
are normal, implies a selective defect in Foxp3-mediated gene
repression. Indeed, several genes that are not associated with
Treg cells were upregulated. Analysis of IL-2, a hallmark
Foxp3-repressed gene, revealed reduced Foxp3 binding to the
IL-2 promoter, concomitant increase in histone acetylation asso-
ciated with the IL-2 promoter, increased promoter activity, and
increased IL-2 production. Collectively, these data suggest
that loss of Foxp3gfp association with Eos, Tip60, and HDAC7
limits nTreg cell function at inflammatory sites and iTreg cell
induction, leading to Treg cell insufficiency and accelerated
autoimmunity in prone environments. We observed substantial
Treg cell insufficiency in two predominantly Th1 cell-driven
disease models, the NOD model of autoimmune diabetes and
after adoptive transfer into Foxp3/ mice, but it is possible
that distinct outcomes would be observed in other disease
models. Indeed, enhanced Foxp3gfp:Irf4 association may
underlie the enhanced Treg cell-mediated suppression of Th2
cell responses and protection from arthritis seen in Foxp3gfp.K/
BxN mice (Darce et al., 2012). The Foxp3gfp reporter mouse
has been a critical tool in advancing our understanding of Treg
cell development, homeostasis, and function (Liston et al.,
2008; Zheng and Rudensky, 2007). Our serendipitous observa-
tion that this broadly utilized Foxp3gfp reporter is a hypomorph
that causes profoundly accelerated autoimmune diabetes on
an NOD background raises questions and opportunities.
Although the numerous studies that have used the Foxp3gfp
reporter are internally controlled (i.e., mutant and wild-type
gene of interest both expressing the Foxp3gfp reporter), the pres-
ence of this hypomorph could potentially exaggerate or mitigate
any enhanced or repressed disease observed, respectively, as
a consequence of introducing unlinked compound mutations.
At the very least, our observations suggest that a review of
published observations with this reporter is warranted. OurImmunity 36, 717–730, May 25, 2012 ª2012 Elsevier Inc. 727
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Foxp3gfp Causes Treg Cell Insufficiencyobservations also send a note of caution to those generating
knockin mutants because seemingly innocuous alterations can
lead to very different consequences in autoimmune-prone or
disease-induced environments.
Despite these concerns, our findings also present a unique
opportunity because the Foxp3gfp hypomorph represents
a new tool that may facilitate further dissection of the complex
processes orchestrated by Foxp3 in mediating Treg cell devel-
opment, homeostasis, and function. Our findings highlight the
physiological contribution of Foxp3 association with Tip60,
HDAC7, and Eos that warrant further study. Furthermore, the
extent of Foxp3 acetylation and ubiquitylation may contribute
a greater role in Treg cell stability than previously realized. Our
data also imply that loss of controlled Foxp3-driven epigenetic
modification may lead to Treg cell insufficiency that ultimately
underlies the accelerated autoimmunity observed in certain
prone environments.
EXPERIMENTAL PROCEDURES
Mice
Foxp3gfp (MGI: Foxp3tm2Ayr) and Foxp3DTR-GFP (MGI: Foxp3tm3Ayr) mice (both
100% C57BL/6 by microsatellite analysis) were provided by S. Rudensky
(Fontenot et al., 2005; Kim et al., 2007). Foxp3gfp mice were bred ten times
onto the NOD background to achieve 100% NOD genetic background based
on microsatellite analysis. Foxp3GFP-hCre NOD (NOD/ShiLT-Tg(Foxp3-EGFP/
cre)1Jbs/J; MGI: Tg(Foxp3-EGFP/cre)1aJbs) BAC transgenic mice were
obtained from The Jackson Laboratory (Zhou et al., 2008). WT and Foxp3gfp
OT-II mice were provided by H. Chi (St. Jude). NOD/LtJ, NOD.SCID, Rag1/,
C57BL/6, and B6.PL-Thy1a/CyJ (Thy1.1 congenic) mice were purchased from
The Jackson Laboratory. NOD mice were monitored weekly for diabetes
onset; mice were considered diabetic when tested positive for glucose in urine
by Clinistix concomitant with blood glucose reading above 400 mg/dl.
All animal experiments were performed in American Association for the
Accreditation of Laboratory Animal Care-accredited, specific-pathogen-free,
Helicobacter-free facilities in the St. Jude Animal Resource Center according
to national, state, and institutional guidelines. Animal protocols were approved
by the St. Jude Animal Care and Use Committee.
Measurement of Insulitis
Insulitis was assessed as described previously (Burton et al., 2008). In brief,
pancreata of NOD mice embedded in paraffin was cut at 4 mm-thick sections
at 150 mm step-sections and stained with hematoxylin and eosin at the
St. Jude Histology Core Facility. An average of 90–100 islets per mouse
were scored in a blindedmanner. See Supplemental Experimental Procedures
for details of insulitis measurement.
Flow Cytometric Analysis and Cell Sorting
Tconv (CD4+CD45RBhiCD25) and Treg (CD4+CD45RBloCD25+) (Biolegend)
cells were positively sorted by FACS on a Reflection (i-Cyt) from spleens
and lymph nodes of WT or Foxp3gfp age-matched mice. Spleens, LNs, and
pancreatic islets were removed, processed, counted, stained, and then
analyzed on a LSRII flow cytometer (BD PharMingen, San Diego, CA). Pancre-
atic islets were isolated as previously reported by flushing the pancreas with
Collagenase 4, then digesting the pancreas and picking the isolated islets
(Burton et al., 2008). Cell surface molecules including CD4, CD25, CXCL3,
and CD103 (Biolegend) were stained with fluorescently conjugated mAbs.
Flow cytometric analysis was performed with a LSR II and data analyzed
with FlowJo 8.8.2 software.
Foxp3–/– Rescue Model
The Foxp3/ rescue model was performed as described previously (Collison
et al., 2010; Workman et al., 2011). In brief, the Treg cell populations indicated
were purified by FACS and injected (106) i.p. into 2- to 3-day-old Foxp3/
mice. On day 35, disease was assessed as a clinical score, and mice were728 Immunity 36, 717–730, May 25, 2012 ª2012 Elsevier Inc.euthanized to determine the number of CD4+ Tconv cells in the spleen and
LN by flow cytometry. In addition, lung, liver, and ear pinna were prepared
for H&E analysis and the severity of inflammation was assessed and scored
in a blinded manner by an experienced veterinary pathologist (J.E.R.).
Induced Treg Cell Assay
In brief, CD4+ Tconv (CD45RBhiCD25) cells were sorted to greater than 99%.
Purity was confirmed by intracellular Foxp3 staining. Cells were plated at
0.2 3 106 per well in a 96-well U-bottom plate and stimulated with anti-CD3/
anti-CD28-coated beads at 1:1 ratio beads to cells, plus 5 ng/ml TGF-b and
100 U/ml IL-2. After 5 days, cells were stained with a Foxp3 antibody and
the percent conversion was calculated.
In Vivo Induced Treg Conversion Assay
In brief, CD4+ Tconv (CD45RBhiCD25) cells were sorted to greater than
98%. Purity was confirmed by intracellular Foxp3 staining. 23 106 Tconv cells
were then injected into Rag1/ mice. After 21 days, spleens and mesenteric
LNs were harvested and stained with anti-CD4 and anti-Foxp3 to
determine Foxp3 induction. For OVA-fed in vivo iTreg cells, CD45.1+ congenic
mice were injected intravenously with a 50:50 ratio of Thy1.1+CD45.2+
CD4+CD45RBhiCD25 Tconv (sorted to greater than 99.7% purity for
Foxp3 Tconv) cells from WT OT-II mice or Thy1.2+CD45.2+CD4+CD45RBhi
CD25 Tconv cells from Foxp3gfp OT-II mice. After 6 days of receiving
water containing OVA antigen (Sigma, 2 g/100 ml), the PP, MLN, spleen, and
peripheral LNs were harvested. Donor cells were determined by first gating
on CD45.2 and CD4, then gating on either Thy1.1 or Thy1.2.
Immunoprecipitation and Immunoblot Analysis
Immunoprecipitation and immunoblotting were performed as described
previously (Pan et al., 2007). Immunoprecipitation experiments were
carried out by using Pierce crosslink IP kit and clean-Blot IP detection system
(Thermo Scientific). The following antibodies were used in the current
study: anti-Foxp3 (eBioscience); anti-Myc, anti-GST, anti-p300, anti-NFAT,
and anti-HDAC7 (Santa Cruz); anti-ubiquitin, anti-Eos, and anti-Flag (Sigma);
anti-Tip60 and anti-acetyllysine (Cell Signaling); and anti-lysine 48 (K48)
(Invitrogen).
Affymetrix Array and Analysis
Wild-type (Foxp3GFP-hCre) or Foxp3gfp NOD Tconv (CD3+CD4+GFP) and Treg
(CD3+CD4+GFP+) splenocytes were sorted twice to greater than 99.0% purity
from 6-week-old mice by FACS and mRNA isolated using TRIZOL (Life Tech-
nologies). Additional methods available in the Supplemental Experimental
Procedures.
Statistical Analysis
Unless otherwise noted in figure legends, statistical significance was deter-
mined with Mann-Whitney unpaired t test. All statistical significance is noted
in figures. In select figures (where noted in legends) statistical analysis was
determined withWilcoxonmatched paired t test. All statistics were determined
with GraphPad Prism software (San Diego, CA).
ACCESSION NUMBERS
The microarray data are available in the Gene Expression Omnibus (GEO)
database (http://www.ncbi.nlm.nih.gov/gds) under the accession number
GSE35164.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and seven figures and can be found with this article online at doi:10.1016/
j.immuni.2012.03.020.
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